Nov 2022 Bioprojet participates in the Congress ” Les Biothérapies arrivent en Allergologie “
Bioprojet will be present at the Congress "Les Biothérapies arrivent en Allergologie". Meet us on November 26 at the Mercure Airport Hotel in Bordeaux....
News
Nov 2022 Bioprojet participates in the “Congrès du Sommeil” in Lille
Bioprojet will be present at the “Congrès du Sommeil” in Lille. Join us on October 24 and 25 for our symposia....
Nov 2022 Bioprojet participates in the “Congrès de Pneumologie et d’Allergologie pédiatrique” in Paris
Bioprojet will be present at the “Congrès de Pneumologie et d'Allergologie pédiatrique”. Meet us from November 18 to 19 at the Maison de la Chimie, in Paris....
Nov 2022 Bioprojet participates in the “Congrès des Échappées Neurologiques” in PREIGNAC
Bioprojet will be present at the “Congrès des Échappées Neurologiques” in PREIGNAC. Join us on November 4, 5 and 6 for our symposia....
Oct 2022 Bioprojet participates in the “Congrès pluridisciplinaire franco-israélien sur le Sommeil et l’Apnée du Sommeil”
Bioprojet will be present at the 5th edition of the “Congrès pluridisciplinaire franco-israélien sur le Sommeil et l’Apnée du Sommeil”. Join us on October 31 for our symposium entitled "New developments in the management of sleepiness and fatigue in your OSA patients"....
Jun 2022 New partnership between Bioprojet and Acino, the distributer of OZAWADE® (pitolisant) for the Saudi and Middle Eastern market
Bioprojet has just signed an exclusive licence contract with Acino, the Zurich-based Swiss pharmaceutical distributor, for the registration, marketing and distribution of pitolisant in Saudi Arabia with possible extension to other Middle Eastern countries....